Clinical Trial Update: The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase II trial evaluating the safety and effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) combined w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Peritoneal Metastasis

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Metastatic Pancreatic Cancer | Phase 2 | Status: RECRUITING